TWiV 1036: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses Florida local transmission of dengue cases reported in Broward and Miami-Dade counties, infants admitted to US intensive care units for RSV infection during the 2022 seasonal peak, long-term risk of death and readmission after hospital admission with COVID-19 among older adults, safety profile and clinical and virological outcomes of Nirmatrelvir-Ritonavir treatment in patients with advanced chronic kidney disease and COVID-19, Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, the effect of corticosteroids, antibiotics, and anticoagulants on the development of post-COVID-19 syndrome in COVID-19 hospitalized patients 6 months after discharge, long COVID and significant activity limitation among adults, incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong, and diabetes following SARS-CoV-2 infection: Incidence, persistence, and implications of COVID-19 vaccination. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Florida local transmission of dengue cases (Outbreak News) Infants admitted to US ICU for RSV infection (JAMA) Long term risk of death and readmission after hospital admission with COVID-19 (BMJ) Outcomes of Nirmatrelvir-Ritonavir Treatment in patients with Kidney disease and COVID-19 (CID) Fluvoxamine vs placebo for outpatients with symptomatic COVID-19 (OFID) The effect of corticosteroids, antibiotics, and anticoagulants on the development of post-COVID-19 syndrome in hospitalized patients (CEM) Long COVID and significant activity limitation among adults (CDC) Incidence of Diabetes following COVID-19 vaccination and SARS-CoV-2 infection (PLOS) Diabetes following SARS-CoV-2 infection (BMJ) Contribute to our Floating Doctors fundraiser at PWB Letters read on TWiV 1036 Dr. Griffin's COVID treatment summary ( pdf ) Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]